Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Hairy Cell

Explore clinical trials studying Leukemia, Hairy Cell. Study availability and eligibility vary by location and protocol.

170 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Hairy Cell trial results

Completed

BRAF Inhibitor, Vemurafenib, in Patients With Relapsed or Refractory Hairy Cell Leukemia

NCT01711632

Conditions
Hairy Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Scripps Clinic La Jolla, California, United States
  • Northwestern University Evanston, Illinois, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes

NCT04233034

Conditions
Diabetes Mellitus, Endocrine System Diseases, Glucose Metabolism Disorders, +13 more
Locations
  • Stanford University Palo Alto, California, United States
  • Barbara Davis Center Aurora, Colorado, United States
  • Yale University New Haven, Connecticut, United States
  • Indiana University Indianapolis, Indiana, United States
View Trial Details
Completed

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

NCT02924402

Conditions
B-Cell Non-Hodgkins Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +50 more
Locations
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Northside Hospital Atlanta, Georgia, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

NCT02175433

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Site US0006 Duarte, California, United States
  • Site US0002 Stanford, California, United States
  • Site US0004 Fairway, Kansas, United States
  • Site US0001 New York, United States
View Trial Details
Completed

Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab

NCT02157181

Conditions
Hairy Cell Leukemia (HCL), Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Community based hemato-oncology medical office Ansbach, Germany
  • Community based hemato-oncology medical office Aschaffenburg, Germany
  • Community based hemato-oncology medical office Celle, Germany
  • St.-Johannes-Hospital Dortmund, Germany
View all 47 locations
View Trial Details

Related conditions